Kirk Barber

696 total citations
27 papers, 337 citations indexed

About

Kirk Barber is a scholar working on Dermatology, Epidemiology and Immunology. According to data from OpenAlex, Kirk Barber has authored 27 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Dermatology, 8 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Kirk Barber's work include Psoriasis: Treatment and Pathogenesis (7 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Dermatology and Skin Diseases (4 papers). Kirk Barber is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Dermatology and Skin Diseases (4 papers). Kirk Barber collaborates with scholars based in Canada, United Kingdom and France. Kirk Barber's co-authors include Alexander K. C. Leung, Charles Lynde, Yves Poulin, Joël Claveau, Lyn Guenther, Etain Cronin, Robert Bissonnette, Wayne Gulliver, Neil H. Shear and John Ashkenas and has published in prestigious journals such as Frontiers in Medicine, Contact Dermatitis and JAMA Dermatology.

In The Last Decade

Kirk Barber

24 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirk Barber Canada	12	249	112	87	75	44	27	337
Irina Turchin Canada	13	256 1.0×	83 0.7×	170 2.0×	64 0.9×	25 0.6×	44	424
Stanislava Tzaneva Austria	11	250 1.0×	48 0.4×	109 1.3×	98 1.3×	13 0.3×	20	351
Håkan Granlund Finland	5	283 1.1×	49 0.4×	53 0.6×	147 2.0×	22 0.5×	6	338
Tsui C. Ling United Kingdom	11	205 0.8×	31 0.3×	51 0.6×	40 0.5×	13 0.3×	20	268
Colin Theng Singapore	12	158 0.6×	55 0.5×	158 1.8×	26 0.3×	15 0.3×	20	287
Luís Uva Portugal	7	153 0.6×	41 0.4×	127 1.5×	25 0.3×	17 0.4×	14	325
Hugh Roberts Australia	10	174 0.7×	51 0.5×	23 0.3×	58 0.8×	79 1.8×	17	300
Lidija Kandolf Sekulović Serbia	8	120 0.5×	24 0.2×	63 0.7×	68 0.9×	71 1.6×	45	296
Peter R. Lane Canada	13	331 1.3×	138 1.2×	77 0.9×	17 0.2×	90 2.0×	22	425
Ezgi Aktaş Karabay Türkiye	8	212 0.9×	57 0.5×	63 0.7×	11 0.1×	22 0.5×	42	314

Countries citing papers authored by Kirk Barber

Since Specialization

Citations

This map shows the geographic impact of Kirk Barber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Barber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Barber more than expected).

Fields of papers citing papers by Kirk Barber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Barber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Barber. The network helps show where Kirk Barber may publish in the future.

Co-authorship network of co-authors of Kirk Barber

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk Barber. A scholar is included among the top collaborators of Kirk Barber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk Barber. Kirk Barber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Ye‐Jean, et al.. (2024). Nocebo effects in systemic therapies for adult plaque psoriasis: A systematic review and meta-analysis. Frontiers in Medicine. 11. 1373520–1373520.

Harris, Kristina M., Dawn E. Smilek, M. Byron, et al.. (2021). Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis. JAMA Dermatology. 157(11). 1306–1306. 19 indexed citations

Barber, Kirk. (2020). Digital Cameras Have Destroyed Medical Photography. Journal of Cutaneous Medicine and Surgery. 24(2). 122–123. 1 indexed citations

Barber, Kirk. (2018). MedArXiv: “To boldly go where no one has gone before”—Star Trek: The Next Generation. Journal of Cutaneous Medicine and Surgery. 22(3). 261–262. 1 indexed citations

Barber, Kirk. (2017). “The Good Physician Treats the Disease; the Great Physician Treats the Patient Who Has the Disease” / «Le bon médecin traite la maladie; le grand médecin traite le patient atteint de la maladie». Journal of Cutaneous Medicine and Surgery. 21(3). 193–194.

Calzavara‐Pinton, Piergiacomo, Merete Hædersdal, Kirk Barber, et al.. (2017). Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT. Journal of Cutaneous Medicine and Surgery. 21(1_suppl). 3S–16S. 29 indexed citations

Papp, Kim, Wayne Gulliver, Charles Lynde, et al.. (2016). 2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009. Journal of Cutaneous Medicine and Surgery. 20(5). 375–431. 26 indexed citations

Guenther, Lyn, Kirk Barber, Gordon E. Searles, et al.. (2015). Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines. Journal of Cutaneous Medicine and Surgery. 19(3). 205–215. 7 indexed citations

Zloty, David, et al.. (2015). Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma. Journal of Cutaneous Medicine and Surgery. 19(3). 239–248. 24 indexed citations

10.

Bourcier, Marc, Kim Papp, Wayne Gulliver, et al.. (2015). Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept. Journal of Cutaneous Medicine and Surgery. 19(6). 561–569. 1 indexed citations

11.

Lynde, Charles, Lyn Guenther, Thomas L. Diepgen, et al.. (2010). Canadian Hand Dermatitis Management Guidelines. Journal of Cutaneous Medicine and Surgery. 14(6). 267–284. 35 indexed citations

12.

Poulin, Yves, et al.. (2010). Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis. Journal of Dermatological Treatment. 21(3). 185–192. 23 indexed citations

13.

Gupta, Aditya K., Richard G. Langley, Charles Lynde, et al.. (2008). ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study. Journal of Cutaneous Medicine and Surgery. 12(6). 268–275. 12 indexed citations

14.

Gupta, Aditya K., Charles Lynde, & Kirk Barber. (2006). Pharmacoeconomic Assessment of Ciclopirox Topical Solution, 8%, Oral Terbinafine, and Oral Itraconazole for Onychomycosis. Journal of Cutaneous Medicine and Surgery. 10(6_suppl). S54–S62. 2 indexed citations

15.

Lynde, Charles, Kirk Barber, Joël Claveau, et al.. (2005). Canadian Practical Guide for the Treatment and Management of Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 8 Suppl 5. 1–9. 17 indexed citations

16.

Langley, Richard G., Aditya K. Gupta, Yves Poulin, et al.. (2004). The Use of Alefacept in the Treatment of Psoriasis. Journal of Cutaneous Medicine and Surgery. 8(S1). 14–18. 8 indexed citations

17.

Lui, Harvey, Richard G. Langley, Yves Poulin, et al.. (2004). Incorporating Biologics into the Treatment of Psoriasis. Journal of Cutaneous Medicine and Surgery. 8(S1). 8–13. 2 indexed citations

18.

Lui, Harvey, Richard G. Langley, Yves Poulin, et al.. (2004). Incorporating Biologics into the Treatment of Psoriasis. Journal of Cutaneous Medicine and Surgery. 8(1_suppl). 8–13.

19.

Leung, Alexander K. C. & Kirk Barber. (2003). Managing childhood atopic dermatitis. Advances in Therapy. 20(3). 129–137. 49 indexed citations

20.

Barber, Kirk. (1983). Allergic contact eczema to phenylephrine. Contact Dermatitis. 9(4). 274–277. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact